Filing Details

Accession Number:
0001209191-21-002371
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-06 19:15:07
Reporting Period:
2021-01-06
Accepted Time:
2021-01-06 19:15:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1681682 Endra Life Sciences Inc. NDRA Electromedical & Electrotherapeutic Apparatus (3845) 260579295
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744025 Bertrand Renaud Maloberti C/O Endra Life Sciences Inc.
3600 Green Court, Suite 350
Ann Arbor MI 48105
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-06 11,269 $0.94 30,311 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold pursuant to a 10b5-1 trading plan to pay withholding taxes due in connection with the vesting of certain restricted stock units.